KR20030053417A - 삼백초를 주성분으로 한 건강식품 - Google Patents
삼백초를 주성분으로 한 건강식품 Download PDFInfo
- Publication number
- KR20030053417A KR20030053417A KR1020010083730A KR20010083730A KR20030053417A KR 20030053417 A KR20030053417 A KR 20030053417A KR 1020010083730 A KR1020010083730 A KR 1020010083730A KR 20010083730 A KR20010083730 A KR 20010083730A KR 20030053417 A KR20030053417 A KR 20030053417A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- jujube
- ginger
- malt
- formulation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 10
- 235000013402 health food Nutrition 0.000 title claims abstract description 9
- 241000534017 Saururus chinensis Species 0.000 title abstract 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 16
- 235000008397 ginger Nutrition 0.000 claims abstract description 16
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 15
- 241000018646 Pinus brutia Species 0.000 claims abstract description 15
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 15
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 14
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 14
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 13
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 11
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 11
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 11
- 230000029142 excretion Effects 0.000 claims abstract description 10
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 7
- 208000008589 Obesity Diseases 0.000 claims abstract description 7
- 201000011510 cancer Diseases 0.000 claims abstract description 7
- 235000020824 obesity Nutrition 0.000 claims abstract description 7
- 240000007594 Oryza sativa Species 0.000 claims abstract description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 6
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- 230000029087 digestion Effects 0.000 claims abstract description 6
- 235000009566 rice Nutrition 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract 2
- 239000008101 lactose Substances 0.000 claims abstract 2
- 235000021329 brown rice Nutrition 0.000 claims description 16
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 15
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 15
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 15
- 229940010454 licorice Drugs 0.000 claims description 15
- 240000000599 Lentinula edodes Species 0.000 claims description 14
- 235000007215 black sesame Nutrition 0.000 claims description 14
- 244000241838 Lycium barbarum Species 0.000 claims description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 13
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 12
- 238000010276 construction Methods 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000007902 hard capsule Substances 0.000 claims description 5
- 230000017531 blood circulation Effects 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 230000004202 respiratory function Effects 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 5
- 239000000469 ethanolic extract Substances 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 9
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 239000002075 main ingredient Substances 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 5
- 235000003434 Sesamum indicum Nutrition 0.000 abstract description 2
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 240000008301 Rhynchosia minima Species 0.000 abstract 1
- 244000000231 Sesamum indicum Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 description 22
- 241000234314 Zingiber Species 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000000284 extract Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000001256 tonic effect Effects 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 6
- 244000046052 Phaseolus vulgaris Species 0.000 description 6
- 241001247821 Ziziphus Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IOLDDENZPBFBHV-UHFFFAOYSA-N Kukoamine A Chemical compound C1=C(O)C(O)=CC=C1CCC(=O)NCCCNCCCCNCCCNC(=O)CCC1=CC=C(O)C(O)=C1 IOLDDENZPBFBHV-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- 239000002221 antipyretic Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- -1 phytosterol Substances 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- YCVPRTHEGLPYPB-VOTSOKGWSA-N trans-pinosylvin Chemical compound OC1=CC(O)=CC(\C=C\C=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-VOTSOKGWSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003579 anti-obesity Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- QRKWLDOOAQAGAE-OAHLLOKOSA-N (1R)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-8-ol Chemical compound O(C)c1c(O)c2[C@@H](Cc3ccc(O)cc3)N(C)CCc2cc1 QRKWLDOOAQAGAE-OAHLLOKOSA-N 0.000 description 2
- LAOVEVDFIVNYLQ-QDQSDLQTSA-N (2s,3r,4s,5r,6r)-2-[[(2r,3r,4s,5r,6s)-6-[[(2r,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@](CO)(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)O1 LAOVEVDFIVNYLQ-QDQSDLQTSA-N 0.000 description 2
- YFZICPBAKZACEG-UHFFFAOYSA-N 1,2-Dehydro-alpha-cyperone Chemical compound C1=CC(=O)C(C)=C2CC(C(=C)C)CCC21C YFZICPBAKZACEG-UHFFFAOYSA-N 0.000 description 2
- QSRIZZQWNHKERT-UHFFFAOYSA-N 5,7-dihydroxy-8-methyl-2-phenyl-2,3-dihydrochromen-4-one Chemical compound O1C=2C(C)=C(O)C=C(O)C=2C(=O)CC1C1=CC=CC=C1 QSRIZZQWNHKERT-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010019133 Hangover Diseases 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- BWRVBFMWWHWLBW-UHFFFAOYSA-N Lyciumin B Chemical compound C12=CC=CC=C2N2C=C1CC(C(O)=O)NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)C)NC(=O)C2NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCCN1C(=O)C1CCC(=O)N1 BWRVBFMWWHWLBW-UHFFFAOYSA-N 0.000 description 2
- YANFYYGANIYHGI-UHFFFAOYSA-N N-carbamoylputrescine Chemical compound NCCCCNC(N)=O YANFYYGANIYHGI-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- LAOVEVDFIVNYLQ-OMMQBQFASA-N Sesamose Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H](O)[C@@H](O)[C@@](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)(CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 LAOVEVDFIVNYLQ-OMMQBQFASA-N 0.000 description 2
- UCQHFDKBUHCAFR-UHFFFAOYSA-N Sesquithujene Natural products CC1=CCC2(C(CCC=C(C)C)C)C1C2 UCQHFDKBUHCAFR-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- VVCHIOKYQRUBED-UHFFFAOYSA-N Zingiberenol Chemical compound CC(C)=CCCC(C)C1CCC(C)(O)C=C1 VVCHIOKYQRUBED-UHFFFAOYSA-N 0.000 description 2
- VVCHIOKYQRUBED-RBSFLKMASA-N Zingiberenol Natural products CC(C)=CCC[C@@H](C)[C@H]1CC[C@](C)(O)C=C1 VVCHIOKYQRUBED-RBSFLKMASA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- YHQIYHDLBZXUON-UHFFFAOYSA-N cepharanone b Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)N4)=C3C4=CC2=C1 YHQIYHDLBZXUON-UHFFFAOYSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- FWWGXZYUURXJLK-UHFFFAOYSA-N glycyrin Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(OC)=CC=2OC(=O)C=1C1=CC=C(O)C=C1O FWWGXZYUURXJLK-UHFFFAOYSA-N 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- MXYATHGRPJZBNA-KRFUXDQASA-N isopimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@@](C=C)(C)CC2=CC1 MXYATHGRPJZBNA-KRFUXDQASA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- QWUHUBDKQQPMQG-UHFFFAOYSA-N pedalitin Chemical compound C=1C(=O)C=2C(O)=C(O)C(OC)=CC=2OC=1C1=CC=C(O)C(O)=C1 QWUHUBDKQQPMQG-UHFFFAOYSA-N 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- YCVPRTHEGLPYPB-UHFFFAOYSA-N pinosylvine Natural products OC1=CC(O)=CC(C=CC=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- UCQHFDKBUHCAFR-KKUMJFAQSA-N sesquithujene Chemical compound CC1=CC[C@]2([C@H](CCC=C(C)C)C)[C@H]1C2 UCQHFDKBUHCAFR-KKUMJFAQSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229930006978 terpinene Natural products 0.000 description 2
- 150000003507 terpinene derivatives Chemical class 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MNNFKQAYXGEKFA-UHFFFAOYSA-N (+)-Juniperol Natural products CC1(C)CCCC2(C)C3(C)C(O)C1C2CC3 MNNFKQAYXGEKFA-UHFFFAOYSA-N 0.000 description 1
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 1
- MHVJRKBZMUDEEV-UHFFFAOYSA-N (-)-ent-pimara-8(14),15-dien-19-oic acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)C=C1CC2 MHVJRKBZMUDEEV-UHFFFAOYSA-N 0.000 description 1
- DXWHOKCXBGLTMQ-UHFFFAOYSA-N (20R,22R)-6alpha,7alpha-epoxy-5alpha,20-dihydroxy-1-oxowitha-2,24-dienolide Natural products C1C(C)=C(C)C(=O)OC1C(C)(O)C1C2(C)CCC3C4(C)C(=O)C=CCC4(O)C4OC4C3C2CC1 DXWHOKCXBGLTMQ-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- LIEMBEWXEZJEEZ-INEUFUBQSA-N (2r,3r)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid Chemical compound NC1=NC=NC2=C1N=CN2C[C@@H](O)[C@@H](O)C(O)=O LIEMBEWXEZJEEZ-INEUFUBQSA-N 0.000 description 1
- NZSLQDJARYZBJR-GANKZJCUSA-N (2s)-2-(dimethylamino)-4-methyl-n-[(2z,6s,9s,10r)-6-(2-methylpropyl)-5,8-dioxo-10-propan-2-yl-11-oxa-4,7-diazabicyclo[10.2.2]hexadeca-1(14),2,12,15-tetraen-9-yl]pentanamide Chemical compound C/1=C/NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N(C)C)CC(C)C)[C@@H](C(C)C)OC2=CC=C\1C=C2 NZSLQDJARYZBJR-GANKZJCUSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- QRKWLDOOAQAGAE-UHFFFAOYSA-N (R)Juziphin Natural products C12=C(O)C(OC)=CC=C2CCN(C)C1CC1=CC=C(O)C=C1 QRKWLDOOAQAGAE-UHFFFAOYSA-N 0.000 description 1
- YFZICPBAKZACEG-DOMZBBRYSA-N 1,2-Dehydro-alpha-cyperone Natural products C1=CC(=O)C(C)=C2C[C@H](C(=C)C)CC[C@]21C YFZICPBAKZACEG-DOMZBBRYSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- IGJQUJNPMOYEJY-UHFFFAOYSA-N 2-acetylpyrrole Chemical compound CC(=O)C1=CC=CN1 IGJQUJNPMOYEJY-UHFFFAOYSA-N 0.000 description 1
- FMUNNDDBCLRMSL-UHFFFAOYSA-N 3,3'-Dihydroxy-isorenieraten Natural products C12CCC3C4(C)CCC(O)C(C)(C)C4CCC3(C)CC2=CCC2C1(C)CCC(O)C2(C)C FMUNNDDBCLRMSL-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 description 1
- MXYATHGRPJZBNA-UHFFFAOYSA-N 4-epi-isopimaric acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)CC1=CC2 MXYATHGRPJZBNA-UHFFFAOYSA-N 0.000 description 1
- QFUXQRHAJWXPGP-BINDOVRGSA-N 5-[(2r,3s,4r,5r)-5-(1,3-benzodioxol-5-yl)-3,4-dimethyloxolan-2-yl]-1,3-benzodioxole Chemical compound C1=C2OCOC2=CC([C@H]2[C@H](C)[C@@H]([C@@H](O2)C=2C=C3OCOC3=CC=2)C)=C1 QFUXQRHAJWXPGP-BINDOVRGSA-N 0.000 description 1
- HSMDOSKNXLVXIP-IRTBSJMASA-N 5-[(2s,3s,4s,5r)-5-(3,4-dimethoxyphenyl)-3,4-dimethyloxolan-2-yl]-1,3-benzodioxole Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](C)[C@H](C)[C@@H](C=2C=C3OCOC3=CC=2)O1 HSMDOSKNXLVXIP-IRTBSJMASA-N 0.000 description 1
- UGTSZVWDFDIWIG-OAHLLOKOSA-N 6-Gingesulfonic acid Natural products S(=O)(=O)(O)[C@@H](CC(=O)CCc1cc(OC)c(O)cc1)CCCCC UGTSZVWDFDIWIG-OAHLLOKOSA-N 0.000 description 1
- UGTSZVWDFDIWIG-UHFFFAOYSA-N 6-Gingesulfonic acid Chemical compound CCCCCC(S(O)(=O)=O)CC(=O)CCC1=CC=C(O)C(OC)=C1 UGTSZVWDFDIWIG-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSRIZZQWNHKERT-AWEZNQCLSA-N 8-Methylpinocembrin Natural products C1([C@@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C)=CC=CC=C1 QSRIZZQWNHKERT-AWEZNQCLSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 229930193366 Amphibine Natural products 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229930188377 Angeloylisogomisin Natural products 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 102100037293 Atrial natriuretic peptide-converting enzyme Human genes 0.000 description 1
- 101710133555 Atrial natriuretic peptide-converting enzyme Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LIEMBEWXEZJEEZ-UHFFFAOYSA-N D-threo-Leutysin Natural products NC1=NC=NC2=C1N=CN2CC(O)C(O)C(O)=O LIEMBEWXEZJEEZ-UHFFFAOYSA-N 0.000 description 1
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 229930185889 Epigomisin Natural products 0.000 description 1
- GWDFJIBHVSYXQL-SYTFOFBDSA-N Epigomisin O Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3[C@H](O)[C@@H](C)[C@@H](C)CC2=CC2=C1OCO2 GWDFJIBHVSYXQL-SYTFOFBDSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WLPHLDLTTPUDSI-UHFFFAOYSA-N Gancaonin G Natural products O=C1C=2C(O)=C(CC=C(C)C)C(OC)=CC=2OC=C1C1=CC=C(O)C=C1 WLPHLDLTTPUDSI-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- IPOLXDNCMOVXCP-YZVVJARPSA-N Lyciumin A Natural products O=C(N[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)O)Cc2c3c(n1c2)cccc3)[C@H](NC(=O)[C@H]1N(C(=O)[C@@H]2NC(=O)CC2)CCC1)Cc1ccc(O)cc1 IPOLXDNCMOVXCP-YZVVJARPSA-N 0.000 description 1
- IPOLXDNCMOVXCP-UHFFFAOYSA-N Lyciumin A Chemical compound C12=CC=CC=C2N2C=C1CC(C(O)=O)NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)C)NC(=O)C2NC(=O)C(NC(=O)C1N(CCC1)C(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 IPOLXDNCMOVXCP-UHFFFAOYSA-N 0.000 description 1
- BARYJIKIMHXXOI-UHFFFAOYSA-N Lyciumin A methylate Natural products O=C1NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(C(=O)OC)CC(C2=CC=CC=C22)=CN2C1NC(=O)C(NC(=O)C1N(CCC1)C(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 BARYJIKIMHXXOI-UHFFFAOYSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- GSWZMFDCPMPHDL-QQXIIUSLSA-N Manassantin B Natural products O([C@@H]([C@H](O)c1cc(OC)c(OC)cc1)C)c1c(OC)cc([C@@H]2[C@H](C)[C@H](C)[C@H](c3cc(OC)c(O[C@@H]([C@H](O)c4cc5OCOc5cc4)C)cc3)O2)cc1 GSWZMFDCPMPHDL-QQXIIUSLSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PPFMQQOEBRCEBH-UHFFFAOYSA-N Mucronin Natural products CC1C2C(OC1=O)C=C(/C)CCC=C(/C)C=C/2O PPFMQQOEBRCEBH-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000013697 Pinus resinosa Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 description 1
- ZANBLNRUVUOABN-UHFFFAOYSA-N Saururenin Natural products C1=C(OC)C(OC)=CC=C1CC(C)C(C)CC1=CC=C(OCO2)C2=C1 ZANBLNRUVUOABN-UHFFFAOYSA-N 0.000 description 1
- AUXKXHAVSAUIQX-UHFFFAOYSA-N Saururin Natural products COc1cc(CC(C)C(C)Cc2ccc3OCOc3c2)cc4OCOc14 AUXKXHAVSAUIQX-UHFFFAOYSA-N 0.000 description 1
- 229930187077 Schizantherin Natural products 0.000 description 1
- OJVGWDJIYBTWDS-AFHBHXEDSA-N Sesamolinol Chemical compound C1=C(O)C(OC)=CC(O[C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 OJVGWDJIYBTWDS-AFHBHXEDSA-N 0.000 description 1
- OJVGWDJIYBTWDS-UHFFFAOYSA-N Sesamolinol Natural products C1=C(O)C(OC)=CC(OC2C3C(C(OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 OJVGWDJIYBTWDS-UHFFFAOYSA-N 0.000 description 1
- 241000207961 Sesamum Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- OZWDYLLMBFLSNH-UHFFFAOYSA-N Swertisin Natural products COc1cc2OC(=CC(=O)c2c(O)c1OC3OC(CO)C(O)C(O)C3O)c4cccc(O)c4 OZWDYLLMBFLSNH-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- JLJAVUZBHSLLJL-GKHNXXNSSA-N Veraguensin Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](C)[C@H](C)[C@H](C=2C=C(OC)C(OC)=CC=2)O1 JLJAVUZBHSLLJL-GKHNXXNSSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- SXPKTVWCWZNDHQ-UHFFFAOYSA-N Withanolide A Natural products CC1=C(C)C(=O)OC(C1)C(CO)C2CCC3C4C5OC5C6(O)CC=CC(=O)C6(C)C4CCC23C SXPKTVWCWZNDHQ-UHFFFAOYSA-N 0.000 description 1
- DXWHOKCXBGLTMQ-SFQAJKIESA-N Withanolide A Chemical compound C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=CC[C@]4(O)[C@H]4O[C@H]4[C@H]3[C@@H]2CC1 DXWHOKCXBGLTMQ-SFQAJKIESA-N 0.000 description 1
- YQOZLXLHUHCYAC-UHFFFAOYSA-N Withanolide B Natural products CC(C1CC(=C(C)C(=O)O1)C)C2CCC3C4C5OC5C6(C)CC=CC(=O)C6(C)C4CCC23C YQOZLXLHUHCYAC-UHFFFAOYSA-N 0.000 description 1
- ZTEVDTFJUUJBLP-MBMSZCMESA-N Withanolide B Chemical compound C([C@@H]1[C@H]([C@@H]2[C@]3(CC[C@@H]4[C@@]5(C)C(=O)C=CC[C@]5(O)[C@H]5O[C@H]5[C@H]4[C@@H]3CC2)C)C)C(C)=C(C)C(=O)O1 ZTEVDTFJUUJBLP-MBMSZCMESA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 229930194752 Zizybeoside Natural products 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- ZSAUXCVJDYCLRS-GDNBJRDFSA-N angeloylgomisin Chemical compound C1C(C)(O)C(C)CC2=CC(OC)=C(OC)C(OC(=O)C(\C)=C/C)=C2C2=C1C=C(OC)C(OC)=C2OC ZSAUXCVJDYCLRS-GDNBJRDFSA-N 0.000 description 1
- 229930186385 angeloylgomisin Natural products 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- OWHIYNVJYMRDOV-GFCCVEGCSA-N aristolactam BII Natural products COc1cc2C(=O)N[C@@H]3Cc4ccccc4c(c1OC)c23 OWHIYNVJYMRDOV-GFCCVEGCSA-N 0.000 description 1
- 239000010059 aristolactam BII Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- TYPSVDGIQAOBAD-HIFRSBDPSA-N atractylon Natural products Cc1coc2C[C@]3(C)CCCC(=C)[C@H]3Cc12 TYPSVDGIQAOBAD-HIFRSBDPSA-N 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- OSEQANKLJOXPBT-UHFFFAOYSA-N calopiptin Natural products COc1ccc(COC2OC(OCc3ccc4OCOc4c3)C(C)C2C)cc1OC OSEQANKLJOXPBT-UHFFFAOYSA-N 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 1
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- NZSLQDJARYZBJR-UHFFFAOYSA-N franganin Natural products C1=CNC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(N(C)C)CC(C)C)C(C(C)C)OC2=CC=C1C=C2 NZSLQDJARYZBJR-UHFFFAOYSA-N 0.000 description 1
- LAESRKLDVMTTQV-UHFFFAOYSA-N galbacin Natural products CC1C(Cc2ccc3OCOc3c2)OC(Cc4ccc5OCOc5c4)C1C LAESRKLDVMTTQV-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930190913 gancaonin Natural products 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 229930195532 gomosin Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 229930182790 isoschizandrin Natural products 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- MNNFKQAYXGEKFA-MJBFILCRSA-N longiborneol Chemical compound CC1(C)CCCC2(C)C3(C)[C@@H](O)C1C2CC3 MNNFKQAYXGEKFA-MJBFILCRSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- ZTEVDTFJUUJBLP-UHFFFAOYSA-N lycium substance B Natural products C1CC2C3C4OC4C4(O)CC=CC(=O)C4(C)C3CCC2(C)C1C(C)C1CC(C)=C(C)C(=O)O1 ZTEVDTFJUUJBLP-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- GSWZMFDCPMPHDL-FZBBBUCASA-N manassantin B Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H](O)[C@@H](C)OC1=CC=C([C@@H]2[C@@H]([C@@H](C)[C@H](O2)C=2C=C(OC)C(O[C@H](C)[C@H](O)C=3C=C4OCOC4=CC=3)=CC=2)C)C=C1OC GSWZMFDCPMPHDL-FZBBBUCASA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 description 1
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003129 oil well Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- SUYJZKRQHBQNCA-LSDHHAIUSA-N pinobanksin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=CC=C1 SUYJZKRQHBQNCA-LSDHHAIUSA-N 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 1
- 235000007221 pinoresinol Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- FMUNNDDBCLRMSL-PIGMOXAFSA-N serratenediol Chemical compound C([C@@H]12)C[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)CC1=CC[C@@H]1[C@]2(C)CC[C@H](O)C1(C)C FMUNNDDBCLRMSL-PIGMOXAFSA-N 0.000 description 1
- LWNLMKGNCOJJGD-UHFFFAOYSA-N serratenediol Natural products CCC1(C)C(O)CCC2(C)C3CCC4C(=CCC5C(C)(CC)C(O)CCC45C)CC3(C)CCC12 LWNLMKGNCOJJGD-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 230000009861 stroke prevention Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- ABRULANJVVJLFI-DGHBBABESA-N swertisin Chemical compound COC1=CC=2OC(C=3C=CC(O)=CC=3)=CC(=O)C=2C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ABRULANJVVJLFI-DGHBBABESA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229930182787 veraguensin Natural products 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 삼백초과에 속하는 삼백초 및 서먹태콩(쥐눈이콩), 대추, 솔잎, 감초, 영지버섯, 표고버섯, 현미, 검은깨, 백출, 구기자, 오미자, 맥아, 계내금, 공사인, 생강, 다시마를 함유한 인체의 건강유지 및 강화, 특히 암의 예방 및 치료와 소화 및 배설기능개선, 혈행개선 및 호흡기능 개선, 피로회복 및 자양강장, 스트레스해소 및 항염증, 당뇨병 및 비만억제에 유용한 건강식품에 관한 것이다.
Description
본 발명은 삼백초과에 속하는 삼백초 및 서먹태콩(쥐눈이콩), 대추, 솔잎, 감초, 영지버섯, 표고버섯, 현미, 검은깨, 백출, 구기자, 오미자, 맥아, 계내금, 공사인, 생강, 다시마를 함유한 인체의 건강유지 및 강화, 특히 암의 예방 및 치료와 소화 및 배설기능개선, 혈행개선 및 호흡기능 개선, 피로회복 및 자양강장, 스트레스해소 및 항염증, 당뇨병 및 비만억제에 유용한 건강식품에 관한 것이다.
지금까지의 삼백초를 주성분으로 한 배설기능개선 식품은 티백, 환 등으로 시판되고 있으나, 단독으로 사용하거나 어성초와의 구분이 없이 사용되고 있는 실정이다. 또한, 일반건강식품의 효능 중에서 특히 항암효능 및 암 예방 효능은 과학적인 기초자료가 없이 전래의 방법을 원용하고 있어 오히려 인체에 부작용을 야기하는 문제점이 있다.
따라서, 본 발명자는 삼백초로부터 항암활성물질을 분리한 현대의 천연물과학 기술(특허출원번호 2000- 0026801)을 기초로 전통 한방의학과의 과학적인 접목을 통하여 건강유지 및 강화에 유용한 본 발명을 완성하였다.
본 발명의 목적은 삼백초를 주성분으로 하며, 서먹태콩(쥐눈이콩), 대추, 솔잎, 감초, 영지버섯, 표고버섯, 현미, 검은깨, 백출, 구기자, 오미자, 맥아, 계내금, 공사인, 생강, 다시마 등의 생리활성효능을 상승작용할 수 있도록 구성하여 인체의 건강유지 및 강화, 특히 암의 예방 및 치료와 소화 및 배설기능개선, 혈행개선 및 호흡기능 개선, 피로회복 및 자양강장, 스트레스해소 및 항염증, 당뇨병 및 비만억제에 유용한 건강식품을 제공하는데 있다.
본 발명에 의한 건강식품에 함유되어 있는 주성분인 삼백초는 후추목 삼백초과에 속하며, 일반적으로 혼용되고 있는 어성초와는 다른 식물이다. 플라보노이드계통의 성분으로는 퀘르세틴(quercetin), 퀘르시트린(quercitrin), 이소퀘르시트린(isoquercitrin), 하이페린(hyperin), 루틴(rutin) 등이, 정유성분으로는 알파-피넨(α-pinene), 캄펜(camphene), 린나룰 (linalool)등이, 안트라퀴논계 성분으로는 피션(physcion), 에모딘(emodin) 등이, 함질소화합물로는 아리스토락탐 BII(aristolactam BII) 등이, 리그난계열의 오리스토비리그난(austrobilignan), 베라구엔신(veraguensin), 구아이신(guaicin), 소서네올(saucerneol), 마나싼틴 A(manassantin A), 마나싼틴 B(manassantin B), 소서넥틴(saucernectin), 소루린(saururin), 소루레닌(saururenin), 소루리논(saururinone), 오스트로리그난 6(austrolignan 6), 칼로핍틴(calopiptin), 갈바신(galbacin), 주오닌 A(zuonin A) 등이, 기타 지방산과 17종의 아미노산 등이 보고되어 있으며, 항산화효과, 항암효과, 간세포활성효과, 항균효과, 해열, 진통, 소염효과, 근원성이완효과, 이소대변효과, 피부미용효과 등이 보고되어 있다. 특히 항암효과는 중국에서 말기간암환자를 대상으로 처방시 90％ 이상의 유효율을 보였다고 보고되었으나 그 항암활성물질은 밝혀지지 않았으나, 본 발명자가 세계 최초로 항암물질을 분리하여 특허를 출원한 바 있다.
서먹태콩(쥐눈이콩, 여우콩)은 콩과에 속하며, 단백질 식품이면서 알칼리성이다. 콩의 지방은 50％가 리놀산이므로 콜레스테롤을 씻어내어 혈관벽을 튼튼하게 한다. 특히, 사포닌(인삼의 주효능)과 비타민E(토코페롤)가 0.1～0.2％가 있어 노화방지에 효과가 있다. 레시틴은 머리의 회전을 원활하게 할 뿐아니라 아세틸콜린 부족으로 생기는 치매를 예방하며 성장기 어린이 뇌세포를 분화시키고 필요한 신경정보가 원활하게 전달되게 하며, 트립신 저해제가 인슐린의 분비를 촉진하고 섬유소가 혈당치의 급격한 상승을 억제하기 때문에 당뇨성 질환에 효과적이다. 단백질 가수분해효소 저해인자(Protein hydrogenase inhibitor), 피트산, 화이토스테롤(phytosterol), 사포닌, 이소플라온 등의 다섯가지 항암물질이 있다고 알려졌다. 또한, 천식, 거담, 기관지염, 페염치료효과가 있는 것으로 밝혀졌다.
대추는 갈매나무과에 속하며, 주요성분으로는 암피빈(amphibine), 대추인(daechuine), 프란가닌(franganin), 주바닌 A(jubanin A), 주바닌 B(jubanin B), 주지핀(juziphine), 뮤크로닌(mucronin), 스워티신(swertisin), 지지베오사이드(zizybeoside), 지지푸신(zizyphusine) 등이 있으며, 한방과 민간에서 신경쇠약, 소화제, 진통, 산후열, 인후염, 해열, 진정, 완화, 흉요통, 경변, 강장, 수렴, 이뇨, 허한, 사지면다통, 불면, 한열 등에 사용되고 있다.
솔잎은 소나무과의 잎으로 대표적인 성분으로는 아비에틱산(abietic acid), 크립토스트로빈(cryptostrobin), 이소피마릭산(isopimaric acid), 롱지보르네올(longiborneol), 펠란드렌(phellandrene), 피노방크신(pinobanksin), 피노레시놀(pinoresinol), 피노실빈(pinosylvin), 세라텐디올(serratenediol), 터피넨(terpinene), 터피놀렌(terpinolene), 피누솔리드(pinusolid), 토레욜(torreyol) 등이 있으며, 당뇨병, 중풍예방, 뇌세포기능향상, 말초혈관확장, 고혈압, 노화방지, 폐결핵, 자양강장, 간질, 화상, 발모, 천식, 백절풍, 종창 등에 사용되고 있다.
감초는 콩과에 속하며, 주요성분으로는 간카오닌(gancaonin), 글리시린(glycirin), 글리시롤(glycirol), 리코라이스사포닌(licoricesaponin), 리퀴리틴(liquiritin), 우랄사포닌(uralsaponin) 등이 있으며, 피로방지, 콜레스테롤대사 촉진, 항암, 항균작용이 있고, 거담, 진해, 오한, 위궤양, 해독, 식중독, 장근골, 보혈, 인후통 등에 사용된다.
영지버섯은 구멍장이버섯과에 속하는 버섯의 자실체로서, 주요성분으로는 에르고스테롤(ergosterol), 쿠마린(coumarin), 만니톨(mannitol), 트레할로스(trehalose), 글루칸(α-glucan, β-glucan) 등이 있으며, 자양강장, 기관지염, 진정, 고혈압, 항암, 위궤양, 강심, 이뇨, 관절염 등에 사용되고 있다.
표고버섯은 대표적인 항암물질인 렌티난(lentinan)이 면역증강제로서 오랫동안 시판되어 오고 있으며, 헥산의 항바이러스(특히 HIV)작용,렌티나신(lentinacin), 컴팩틴(compactin)의 콜레스테롤 생합성 저해작용에 의한 고지혈증 치료효과, 식이섬유의 정장작용에 의한 변비예방 및 발암성물질의 배설촉진효능 등이 밝혀졌다.
현미는 벼과에 속하는 벼의 쌀겨와 씨눈이 있도록 도정한 것으로, 피를 맑게 하는 비타민 K와 간질환을 치료해주는 코린 등이 있으며, 인체내에 축적돼있는 지방질을 흡수해 배설시키키는 작용으로 다이어트에 적합하며 고혈압, 비만, 당뇨의 치료효과가 밝혀졌다.
검은깨는 참깨과에 속하며, 주요성분으로는 세사모리놀(sesamolinol), 세사모스(sesamose), 페달리틴(pedalitin), 페달린(pedalin), 카바모일프트레사인(N-carbamoyl-putrescine) 등이 보고되어 있으며, 신농본초경에서는 간·심장·비장·폐·신장의 기능을 보호해 원기와 체력을 증강시키고 머리를 충실하게 하며, 몸을 가볍게 하는 것으로 기록되어 있다. 특히 필수아미노산에 의한 뇌를 맑게 해주는 작용, 칼슘, 철분, 비타민 등 각종 미네랄이 풍부하여 뼈를 튼튼하게 해주며, 자양강장, 창종, 양모, 신경쇠약, 해독, 진통, 화상, 치통, 사지산통, 고혈압, 동맥경화증, 당뇨병, 항암 등에 사용된다.
백출은 일명 삽주라 불리고 국화과에 속하며, 주요성분으로는 아트락틸레놀라이드(atractylenolide), 아트락틸론(atractylon), 다이아세틸아트락틸로디올(diacetylatractylediol) 등이 있으며, 방향제, 건위, 지한, 하리, 해열, 중풍, 이뇨, 결막염, 고혈압, 현기증, 발한, 방향성건위 등에 사용된다.
구기자는 가지과에 속하며, 주요성분으로는 아세틸피롤(acetylpyrrole), 디하이드로시페론(1,2-dehydro-α-cyperone), 쿠코아민 A(kukoamine A), 리시우민 A(lyciumin A), 리시우민 B(lyciumin B), 위타놀라이드 A(withanolide A), 위타놀라이드 B(withanolide B) 등이 있으며, 항암, 면역증강, 항균, 간기능개선, 항당뇨효과, 항산화효과, 소염, 해열, 강장, 치통, 음양, 근골 등에 사용된다. 특히 많이 함유하고 있는 베타인(betaine)은 간장과 위장의 기능촉진, 동맥경화와 고혈압 예방 및 개선, 근골강화와 빈혈예방, 루틴(rutin)의 항고혈압 기능, 쿠코아민 A(kukoamine A)의 해열 및 혈압강화 작용, 베타시토스테롤(β-sitisterol)의 콜레스테롤 흡수 효과로 고지혈증 치료 효과 등이 밝혀졌다.
오미자는 목련과에 속하며, 주요성분으로는 고미신 A-T(gomosin A-T), 안젤로일고미신(angeloylgomisin), 안젤로일이소고미신(angeloylisogomisin), 에피고미신(epigomisin), 데옥시쉬잔드린(deoxyschizandrin), 이소쉬잔드린(isoschizandrin), 쉬잔드린(schizandrin), 쉬잔테린(schizantherin) 등이 있으며, 간질환치료, 숙취해소, 음위, 해소, 천식, 단독, 자양강장, 수렴, 발모 등에 사용된다.
맥아는 겉보리에 수분·온도·산소를 작용시켜 발아시킨 보리의 낟알로서, 맥주 양조의 원료로서 중요하고, 미생물의 배양기(培養基)를 조제하는 데도 많이 쓰인다. 녹말과 같은 당류(糖類), 비타민류가 들어 있으며, 가축의 사료, 엿당의 제조원료로 사용되기도 하며, 아밀라아제가 강하여 영양제·소화제(디아스타아제 등) 등으로 이용된다.
계내금은 닭의 모래주머니로서, 소화불량, 식욕부진, 유뇨, 유정, 이뇨, 여성대하 등에 사용된다.
공사인은 생강과에 속하며, 복부팽만, 식체 등의 소화불량과 원기회복 등에 사용된다.
생강은 생강과에 속하며, 진저디온(gingerdione), 진저레논(gingerenone), 진저롤(gingerol), 진제설폰산(6-gingesulfonic acid), 이소진저레논(isogingerenone), 세스퀴펜란드렌(sesquiphellNDRENE), 세스퀴사비넨하이드레이트(sesquinsabinene hydrate), 세스퀴츄젠(sesquithujene), 진지베레놀(zingiberenol) 등이 있으며, 건위, 거담, 지혈, 중풍, 구토, 곽란, 설사, 변비 등에 사용된다.
다시마는 다시마과에 속하는 해조류로서, 주요성분으로는 다이하이드록시프로필리보퓨라노사이드(2',3'-dihydroxypropylribofuranoside), 필수아미노산 17종, 식이섬유, 알긴산(alginic acid), 라미나린(laminarin), 칼슘(Ca), 요오드(I), 칼륨(K), 라미닌(laminin) 등이 있으며, 항암, 수종, 비만, 고혈압, 성장촉진, 양모, 각기, 갑상선종, 해소, 기관지염 등에 사용된다.
본 발명은 다음의 실시예를 통하여 상세히 설명한다. 간, 다음의 실시예는 본 발명을 예시하는 것이며, 본 발명의 내용이 이에 한정하는 것이 아니다.
＜실시예 1＞ 조성물의 재료의 준비
1. 삼백초 : 말린 전초를 사용한다.
2. 서먹태콩(쥐눈이콩) : 씹어서 비린내가 완전히 제거될 때 까지 잘 볶아서사용한다.
3. 대추 : 육질을 잘게 자르고서 햇볕에 완전히 바싹 말려야 한다.
4. 솔잎 : 가능하면 일년생의 왜송 또는 적송을 중성세제로 깨끗이 씻어서 끊는 물에 넣고 1분간 끓인 다음 음지에서 따뜻한 상태로 완전히 말려서 사용한다.
5. 감초 : 그냔 사용한다.
6. 영지버섯 : 잘 건조된 것을 사용한다.
7. 표고버섯 : 잘 건조된 것을 사용한다.
8. 현미 : 잘 건조된 것을 사용한다. 현미씨를 사용하여도 좋다.
9. 검은깨 : 노릿노릿하게 볶아야 하며, 분쇄시에도 분리하여 준비하여야 한다.
10. 백출 : 미지근한 물에다 백출을 담그어서 현미가루를 이용하여 하루정도 담그어 기름을 제거하고 불에다 노릿노릿하게 볶아서 사용한다.
11. 구기자 : 햇볕에 잘 말리어 사용한다.
12. 오미자 : 햇볕에 잘 말리어 사용한다.
13. 맥아초 : 노릿노릿하게 볶아서 사용한다.
14. 계내금 : 노릿노릿하게 볶아서 사용한다.
15. 공사인 : 노릿노릿하게 볶아서 사용한다.
16. 생강 : 건강을 사용한다.
17. 다시마 : 염분을 완전히 제거해야 한다. 물로 깨끗이 씻어 냄새를 제거한 후 말리어 사용한다.
＜실시예 2＞ 과립제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 6.82중량％, 검은깨 6.82중량％, 백출 4.55중량％, 구기자 4.55중량％, 오미자 4.55중량％, 맥아 4.55중량％, 계내금 4.55중량％, 공사인 2.27중량％, 생강 4.55중량％, 다시마 2.27중량％를 통상의 과립제조방법에 따라 제조하였다.
＜실시예 3＞ 추출물 과립제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 6.82중량％, 검은깨 6.82중량％, 백출 4.55중량％, 구기자 4.55중량％, 오미자 4.55중량％, 맥아 4.55중량％, 계내금 4.55중량％, 공사인 2.27중랑％, 생강 4.55중량％, 다시마 2.27중량％를 물이나 에탄올로 추출한 다음 추출물을 말려서 통상의 과립제조방법에 따라 제조하였다.
＜실시예 4＞ 산제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 6.82중량％, 검은깨 6.82중량％, 백출 4.55중량％, 구기자 4.55중량％, 오미자 4.55중량％, 맥아 4.55중량％, 계내금 4.55중량％, 공사인 2.27중량％, 생강 4.55중량％, 다시마 2.27중량％를 통상의 산제제조방법에 따라 제조하였다.
＜실시예 5＞ 추출물 산제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 6.82중량％, 검은깨 6.82중량％, 백출 4.55중량％, 구기자 4.55중량％, 오미자 4.55중량％, 맥아 4.55중량％, 계내금 4.55중량％, 공사인 2.27중량％, 생강 4.55중량％, 다시마 2.27중량％를 물이나 에탄올로 추출한 다음 추출물을 말려서 통상의 산제제조방법에 따라 제조하였다.
＜실시예 6＞ 경질캅셀제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 6.82중량％, 검은깨 6.82중량％, 백출 4.55중량％, 구기자 4.55중량％, 오미자 4.55중량％, 맥아 4.55중량％, 계내금 4.55중량％, 공사인 2.27중량％, 생강 4.55중량％, 다시마 2.27중량％를 내용물의 최종 중량을 500mg으로 하여 통상의 경질캅셀 제조방법에 따라 제조하였다.
＜실시예 7＞ 추출물 경질캅셀제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 6.82중량％, 검은깨 6.82중량％, 백출 4.55중량％, 구기자 4.55중량％, 오미자 4.55중량％, 맥아 4.55중량％, 계내금 4.55중량％, 공사인 2.27중량％, 생강 4.55중량％, 다시마 2.27중량％를 물이나 에탄올로 추출한 다음 추출물을 말려서 내용물의 최종 중량을 200mg으로 하여 통상의 경질캅셀 제조방법에 따라 제조하였다.
＜실시예 8＞ 정제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 5.82중량％, 검은깨 5.82중량％, 백출 3.55중량％, 구기자 3.55중량％, 오미자 3.55중량％, 맥아 3.55중량％, 계내금 3.55중량％, 공사인 1.27중량％, 생강 3.55중량％, 다시마 1.27중량％, 전분 10중량％를 내용물의 최종 중량을 500mg으로 하여 통상의 정제 제조방법에 따라 제조하였다.
＜실시예 9＞ 추출물 정제
삼백초 13.6중량％, 서먹태콩(쥐눈이콩) 9.1중량％, 대추 9.1중량％, 솔잎 6.82중량％, 감초 2.27중량％, 영지버섯 6.82중량％, 표고버섯 6.82중량％, 현미 5.82중량％, 검은깨 5.82중량％, 백출 3.55중량％, 구기자 3.55중량％, 오미자 3.55중량％, 맥아 3.55중량％, 계내금 3.55중량％, 공사인 1.27중량％, 생강 3.55중량％, 다시마 1.27중량％, 전분 10중량％를 물이나 에탄올로 추출한 다음 추출물을 말려서 내용물의 최종 중량을 200mg으로 하여 통상의 정제 제조방법에 따라 제조하였다.
본 발명에 의한 건강식품은 삼백초의 항암, 항비만, 숙변제거 등의 효능, 서먹태콩(쥐눈이콩)의 항암, 혈당하강, 노화방지 등의 효능, 대추의 진정, 해열, 강장 등의 효능, 솔잎의 혈당 하강, 중풍예방, 뇌세포기능향상, 말초혈관확장, 혈압강하, 노화방지 등의 효능, 감초의 피로방지, 콜레스테롤대사 촉진, 항암, 항균 등의 효능, 영지버섯의 자양강장, 진정, 혈압강하, 항암 등의 효능, 표고버섯의 항암, 고지혈증 치료효과, 식이섬유의 정장작용에 의한 변비예방 및 발암성물질의 배설촉진 등의 효능, 현미의 간질환치료, 지방질 흡수 및 배설, 혈압강하, 항비만, 혈당강하 등의 효능, 검은깨의 혈압강하, 혈중 콜레스테롤 제거, 혈당강하, 항암 등의 효능, 백출의 항암, 중풍예방, 혈압강하 등의 효능, 구기자의 항암, 면역증강, 항균, 간기능개선, 혈당강하, 고지혈증개선 등의 효능, 오미자의 간질환치료, 숙취해소, 음위, 자양강장 등의 효능, 맥아, 계내금, 공사인의 소화기능 개선 효능, 생강의 소화 및 배설기능 개선 등의 효능, 다시마의 항암, 항비만, 혈압강하, 성장촉진 효능 등의 생리활성효능 등을 상승작용할 수 있도록 구성하였으므로 인체의 건강유지 및 강화, 특히 암의 예방 및 치료와 소화 및 배설기능개선, 혈행개선 및 호흡기능 개선, 피로회복 및 자양강장, 스트레스해소 및 항염증, 당뇨병 및 비만억제에 탁월하며 인체에 대한 부작용이 없다.
Claims (4)
- 삼백초 5-49중량％, 서먹태콩(쥐눈이콩) 2-20중량％, 대추 2-20중량％, 솔잎 2-20중량％, 감초 2-20중량％, 영지버섯 2-20중량％, 표고버섯 2-20중량％, 현미 2-20중량％, 검은깨 2-20중량％, 백출 2-20중량％, 구기자 2-20중량％, 오미자 2-20중량％, 맥아 2-10중량％, 계내금 2-10중량％, 공사인 1-10중량％, 생강 2-10중량％, 다시마 1-10중량％, 유당 2-10중량％, 전분 5-20중량％를 혼합하여 구성되는 것을 특징으로 하는 암의 예방 및 치료, 소화 및 배설기능개선, 혈행 및 호흡기능 개선, 피로회복 및 자양강장, 스트레스해소 및 항염증, 혈당강하 및 비만억제에 유용한 건강식품.
- 제 1항에 있어서, 제형은 과립제, 산제, 연질캅셀제, 경질캅셀제, 정제, 환제인 것을 특징으로 한다.
- 제 2항에 있어서, 제형의 내용물은 조성재료의 분말, 또는 물이나 에탄올 추출물의 농축분말을 포함한다.
- 제 1항에 있어서, 물이나 에탄올 추출물의 농축액을 사용하는 제형을 포함한다.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020010083730A KR20030053417A (ko) | 2001-12-22 | 2001-12-22 | 삼백초를 주성분으로 한 건강식품 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020010083730A KR20030053417A (ko) | 2001-12-22 | 2001-12-22 | 삼백초를 주성분으로 한 건강식품 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20030053417A true KR20030053417A (ko) | 2003-06-28 |
Family
ID=29578003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020010083730A KR20030053417A (ko) | 2001-12-22 | 2001-12-22 | 삼백초를 주성분으로 한 건강식품 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20030053417A (ko) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030073734A (ko) * | 2002-03-13 | 2003-09-19 | 백대진 | 건강식품의 제조방법 |
| EP1845806A1 (en) * | 2005-02-04 | 2007-10-24 | Heon Sang Jeong | Drinking water for a diabetic and manufacturing process thereof |
| KR101009904B1 (ko) * | 2006-02-10 | 2011-01-20 | 바이오스펙트럼 주식회사 | 천연 식물 추출물을 포함하는 항염 조성물 |
| CN102366104A (zh) * | 2011-10-29 | 2012-03-07 | 山西振东五和健康食品股份有限公司 | 一种用于肿瘤患者的营养食品 |
| CN102920819A (zh) * | 2011-08-10 | 2013-02-13 | 深圳太太药业有限公司 | 一种消食口服液及其制备方法 |
| CN103798799A (zh) * | 2014-03-05 | 2014-05-21 | 哈尔滨灵椿味道食品开发有限公司 | 一种当归舒心解郁火锅料及生产方法 |
| WO2015072596A1 (ko) * | 2013-11-14 | 2015-05-21 | 씨제이헬스케어 주식회사 | 맥아 효소액을 이용한 생약 추출물의 제조방법 |
| EP3023103A1 (en) * | 2014-11-19 | 2016-05-25 | Korea Institute of Oriental Medicine | Pharmaceutical composition for anti-obesity comprising complex extracts including Saururi chinensis Baill. extract, Curcumae longae rhizoma extract and Polygalae radix extract |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970009607A (ko) * | 1995-08-24 | 1997-03-27 | 피영준 | 삼백초 (근) 를 주재로한 갱년기 건강보조식품 제조법 |
| JPH10120583A (ja) * | 1996-10-21 | 1998-05-12 | Noevir Co Ltd | 抗アレルギー剤、ケミカルメディエーター遊離抑制剤及びこれを含有する抗アレルギー性化粧料，医薬品並びに食品 |
| JPH10251155A (ja) * | 1997-03-10 | 1998-09-22 | Shiseido Co Ltd | プロテアーゼ阻害剤 |
| KR100248942B1 (ko) * | 1997-09-30 | 2000-04-01 | 신동권 | 항암 효과를 가지는 삼백초 추출물 및 그의 제조방법 |
| KR100370814B1 (ko) * | 2000-01-11 | 2003-02-05 | 충청북도 농업기술원 | 삼백초 과립 추출차와 그 제조방법 |
-
2001
- 2001-12-22 KR KR1020010083730A patent/KR20030053417A/ko not_active IP Right Cessation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970009607A (ko) * | 1995-08-24 | 1997-03-27 | 피영준 | 삼백초 (근) 를 주재로한 갱년기 건강보조식품 제조법 |
| JPH10120583A (ja) * | 1996-10-21 | 1998-05-12 | Noevir Co Ltd | 抗アレルギー剤、ケミカルメディエーター遊離抑制剤及びこれを含有する抗アレルギー性化粧料，医薬品並びに食品 |
| JPH10251155A (ja) * | 1997-03-10 | 1998-09-22 | Shiseido Co Ltd | プロテアーゼ阻害剤 |
| KR100248942B1 (ko) * | 1997-09-30 | 2000-04-01 | 신동권 | 항암 효과를 가지는 삼백초 추출물 및 그의 제조방법 |
| KR100370814B1 (ko) * | 2000-01-11 | 2003-02-05 | 충청북도 농업기술원 | 삼백초 과립 추출차와 그 제조방법 |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030073734A (ko) * | 2002-03-13 | 2003-09-19 | 백대진 | 건강식품의 제조방법 |
| EP1845806A1 (en) * | 2005-02-04 | 2007-10-24 | Heon Sang Jeong | Drinking water for a diabetic and manufacturing process thereof |
| EP1845806A4 (en) * | 2005-02-04 | 2010-09-29 | Nat Univ Chungbuk Ind Acad | DRINKING WATER FOR DIABETICS AND MANUFACTURING METHOD THEREFOR |
| KR101009904B1 (ko) * | 2006-02-10 | 2011-01-20 | 바이오스펙트럼 주식회사 | 천연 식물 추출물을 포함하는 항염 조성물 |
| CN102920819A (zh) * | 2011-08-10 | 2013-02-13 | 深圳太太药业有限公司 | 一种消食口服液及其制备方法 |
| CN102366104A (zh) * | 2011-10-29 | 2012-03-07 | 山西振东五和健康食品股份有限公司 | 一种用于肿瘤患者的营养食品 |
| CN102366104B (zh) * | 2011-10-29 | 2012-12-05 | 山西振东五和健康食品股份有限公司 | 一种用于肿瘤患者的营养食品 |
| WO2015072596A1 (ko) * | 2013-11-14 | 2015-05-21 | 씨제이헬스케어 주식회사 | 맥아 효소액을 이용한 생약 추출물의 제조방법 |
| CN103798799A (zh) * | 2014-03-05 | 2014-05-21 | 哈尔滨灵椿味道食品开发有限公司 | 一种当归舒心解郁火锅料及生产方法 |
| EP3023103A1 (en) * | 2014-11-19 | 2016-05-25 | Korea Institute of Oriental Medicine | Pharmaceutical composition for anti-obesity comprising complex extracts including Saururi chinensis Baill. extract, Curcumae longae rhizoma extract and Polygalae radix extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| KR100510239B1 (ko) | 옥수수 수염과 식이섬유를 함유하는 조성물의 제조방법 | |
| KR101136090B1 (ko) | 기능성 식품 및 이의 제조방법 | |
| CN107156623A (zh) | 一种复合谷物混合物及其制备方法 | |
| CN104770824A (zh) | 一种补气养血保健冲料 | |
| KR20160087114A (ko) | 꽃을 이용한 식품첨가제 | |
| CN103609992B (zh) | 一种高丽红参膏的制备方法 | |
| KR101018065B1 (ko) | 대추를 사용한 건강음료 제조방법 및 이에 의해 제조된 건강음료 | |
| US20200147166A1 (en) | Health supplement food for promotion of hair growth, mitigation and alleviation of hair loss, regulation of blood glucose, and alleviation and relief of gastric disorder symptoms | |
| CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
| KR20120056425A (ko) | 탈모에 효과적인 건강보조식품 및 그 제조방법 | |
| KR101632794B1 (ko) | 흰점박이 꽃무지를 주재료로 하는 환의 제조방법 | |
| KR20130104692A (ko) | 산사육 추출물을 함유하는 비만치료 및 예방용 조성물 | |
| KR20090127970A (ko) | 생식환의 조성물 및 이의 제조 방법 | |
| CN104738640A (zh) | 一种高丽红参膳食纤维大豆蛋白膨化粉的制备方法 | |
| JP2016077283A (ja) | 農産物と穀物菌糸体とが混合され、発酵された抗癌、抗糖尿、免疫増進用の発酵禅食組成物及びその製造方法｛Ｆｅｒｍｅｎｔｅｄｆｏｏｄｃｏｍｐｏｓｉｔｉｏｎｃｏｍｐｒｉｓｉｎｇａｇｒｉｃｕｌｔｕｒａｌｐｒｏｄｕｃｔｓａｎｄｍｙｃｅｌｉｕｍｍｉｘｔｕｒｅｆｏｒｐｒｅｖｅｎｔｉｎｇｏｒｔｒａｔｉｎｇｃａｎｃｅｒ、ｄｉａｂｅｔｉｃｓａｎｄｉｍｐｒｏｖｉｎｇｉｍｍｕｎｅｆｕｎｃｔｉｏｎ、ａｎｄｐｒｅｐａｒａｔｉｏｎｍｅｔｈｏｄｔｈｅｒｅｏｆ｝ | |
| KR20070013114A (ko) | 차 조성물 | |
| KR101788253B1 (ko) | 고량강, 풀솜대 및 흑마늘을 유효성분으로 포함하는 남성 성기능 개선용 조성물 | |
| CN103478560B (zh) | 一种用牛奶和绞股蓝制造的营养大米 | |
| CN110583974A (zh) | 一种瘦身全谷营养健康代餐食品及其制备方法 | |
| KR20030053417A (ko) | 삼백초를 주성분으로 한 건강식품 | |
| KR101999675B1 (ko) | 관상동맥성 심장질환의 예방과 치료용 생약조성물 | |
| KR20090038595A (ko) | 보양식 순대소 조성물 및 그를 이용한 순대 제조방법 | |
| KR102215936B1 (ko) | 밤을 포함하는 피로회복용 쌍화탕 건강기능식품 조성물 및 그 제조방법 | |
| CN107308266A (zh) | 一种女性养生保健组合物及制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| N231 | Notification of change of applicant | ||
| N231 | Notification of change of applicant | ||
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| SUBM | Submission of document of abandonment before or after decision of registration |